The Genetics of Alzheimer's Disease: Progress, Possibilities, and Pitfalls

References

• Goate A, Chartier-Harlin M, Mullan MC, Brown J, Crawford F, Fidani L, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349: 704–6
   PubMed Web of Science ®Google Scholar
• Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995; 375: 754–60
   PubMed Web of Science ®Google Scholar
• Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995; 269: 973–7
   PubMed Web of Science ®Google Scholar
• Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, et al. Apolipoprotein E: high-avidity binding to bˆ-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993; 90: 1977–81
   PubMed Web of Science ®Google Scholar
• Saunders AM, Strittmatter WJ, Schmechel D, St George-Hyslop PH, Pericak-Vance MA, Joo SH, et al. Association of apolipoprotein E allele ϵ4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43: 1467–72
   PubMed Web of Science ®Google Scholar
• Tanzi RE, Kovacs DM, Kim TW, Moir RD, Guenette SY, Wasco W. The gene defects responsible for familial Alzheimer's disease. Neurobiol Dis 1996; 3: 159–68
   PubMed Web of Science ®Google Scholar
• Sorbi S, Nacmias B, Forleo P, Piacentini S, Latorraca S, Amaducci L. Epistatic effect of APP717 mutation and apolipoprotein E genotype in familial Alzheimer's disease. Ann Neurol 1995; 38: 124–7
   Google Scholar
• Van Broeckhoven C, Backhovens H, Cruts M, Martin JJ, Crook R, Houlden H, et al. APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease. Neurosci Lett 1994; 169: 179–80
   PubMedGoogle Scholar
• Farrer LA, Myers RH, Cupples LA, St George-Hyslop PH, Bird TD, Rossor MN, et al. Transmission and age-at-onset patterns in familial Alzheimer's disease: evidence for heterogeneity. Neurology 1990; 40: 395–403
   Google Scholar
• Lautenschlager NT, Cupples LA, Rao VS, Auerbach SA, Becker R, Burke J, et al. Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: what is in store for the oldest old?. Neurology 1996; 46: 641–50
   PubMed Web of Science ®Google Scholar
• Bergem AL, Engedal K, Kringlen E. The role of heredity in late-onset Alzheimer disease and vascular dementia: a twin study. Arch Gen Psychiatry 1997; 54: 264–70
   PubMed Web of Science ®Google Scholar
• Katzman R, Kawas C. The epidemiology of dementia and Alzheimer disease. Alzheimer disease, RD Terry, R Katzman, KL Bick. Raven, New York 1997; 105–22
   Google Scholar
• Schellenberg GD. Genetic dissection of Alzheimer, disease, a heterogeneous, disorder. Proc Natl Acad Sci, USA 1995; 92: 8552–9
   PubMed Web of Science ®Google Scholar
• Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ. Prevalence of Alzheimer's disease in a community population of older persons: higher than previously reported. JAMA 1989; 262: 2551–6
   PubMed Web of Science ®Google Scholar
• Blacker D, Haines JL, Rodes L, Terwedow H, Go RCP, Harrell LE, et al. ApoE-4 and age at onset of Alzheimer's disease: the NIMH Genetics Initiative. Neurology 1997; 48: 139–47
   PubMed Web of Science ®Google Scholar
• Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC, Jr, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 1994; 7: 180–4
   PubMed Web of Science ®Google Scholar
• Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921–3
   PubMed Web of Science ®Google Scholar
• Locke PA, Conneally PM, Tanzi RE, Gusella JF, Haines JL. Apolipoprotein E4 allele and Alzheimer disease: examination of allelic association and effect on age at onset in both early-and late-onset cases. Genet Epidemiol 1995; 12: 83–92
   Google Scholar
• Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Jr, Rimmler JB, et al. Apolipoprotein, E, survival in Alzheimer's disease, patients, and the competing risks of death and Alzheimer's, disease. Neurology 1995; 45: 1323–8
   PubMed Web of Science ®Google Scholar
• Rebeck GW, Perls TT, West HL, Sodhi P, Lipsitz LA, Hyman BT. Reduced apolipoprotein ϵ4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. Neurology 1994; 44: 1513–6
   PubMed Web of Science ®Google Scholar
• American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer Disease. Statement on use of apolipoprotein E testing for Alzheimer disease. JAMA 1995; 274: 1627–9
   PubMed Web of Science ®Google Scholar
• National Institute on Aging/Alzheimer's Association Working Group. Apolipoprotein E genotyping in Alzheimer's disease. Lancet 1996; 347: 1091–5
   PubMed Web of Science ®Google Scholar
• Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F bˆ-amyloid precursor protein. Nature 1995; 373: 523–7
   PubMed Web of Science ®Google Scholar
• Albert MS. The science of the mind. Science 1997; 275: 1547
   Google Scholar
• American Psychiatric Association. Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late life. Am J Psychiatry 1997; 154: 1–39, 5, suppl
   PubMed Web of Science ®Google Scholar